Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER

202427 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Genetics in Medicine

Volume 26, Issue 7, pp. 101138-101138

Field-Weighted Citation Impact: 5.96